These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The effects of opiate agonists on growth hormone and prolactin release in rats. Shaar CJ; Clemens JA Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214 [TBL] [Abstract][Full Text] [Related]
26. Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas. Arnerić SP; Chow SA; Long JP; Fischer LJ J Pharmacol Exp Ther; 1984 Mar; 228(3):551-9. PubMed ID: 6142939 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats. Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926 [TBL] [Abstract][Full Text] [Related]
28. Evidence for the involvement of dopaminergic neurons in the pregnancy block effect. Marchlewska-Koj A; Jemioło Neuroendocrinology; 1978; 26(3):186-92. PubMed ID: 683469 [TBL] [Abstract][Full Text] [Related]
29. The role of dopamine and serotonin in the discriminative stimulus effects of lisuride. White FJ; Appel JB J Pharmacol Exp Ther; 1982 May; 221(2):421-7. PubMed ID: 7077537 [TBL] [Abstract][Full Text] [Related]
30. On some central effects of elymoclavine. Roussinov K; Georgiev V; Petkov V; Lazarova M; Petkova B; Shopova S; Markovska V; Getova D; Draganova S Acta Physiol Pharmacol Bulg; 1984; 10(4):28-35. PubMed ID: 6442955 [TBL] [Abstract][Full Text] [Related]
31. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia. Fuller RW; Clemens JA; Hynes MD J Clin Psychopharmacol; 1982 Dec; 2(6):371-5. PubMed ID: 7174859 [TBL] [Abstract][Full Text] [Related]
33. Temporal relationship and role of dopamine in "short-loop" feedback of prolactin. Advis JP; Hall TR; Hodson CA; Mueller GP; Meites J Proc Soc Exp Biol Med; 1977 Sep; 155(4):567-70. PubMed ID: 561399 [No Abstract] [Full Text] [Related]
34. Effect of morphine on the dopamine inhibition of pituitary prolactin release in vitro. Enjalbert A; Ruberg M; Fiore L; Arancibia S; Priam M; Kordon C Eur J Pharmacol; 1979 Jan; 53(2):211-2. PubMed ID: 759199 [No Abstract] [Full Text] [Related]
35. [Effect of some drugs on the hormonal function of rat's ovaries chronically poisoned by carbon disulfide]. Stanosz S; Rózewicki S; Samochowiec L Ann Acad Med Stetin; 1973; 0(8):suppl 8:107-8. PubMed ID: 4807605 [No Abstract] [Full Text] [Related]
36. Ergoline congeners as potential inhibitors of prolactin release. 2. Rusterholz DB; Barfknecht CF; Clemens JA J Med Chem; 1976 Jan; 19(1):99-102. PubMed ID: 1246056 [TBL] [Abstract][Full Text] [Related]
37. Pulsatile secretion of prolactin in the male rat after pimozide administration is not due to pulsatile inhibition of PIF secretion. Shin SH Life Sci; 1979 May; 24(19):1751-6. PubMed ID: 37393 [No Abstract] [Full Text] [Related]
38. Reduction of antineoplastic drug intoxication by 5-hydroxytryptamine antagonists. Fregnan GB; Glässer AH Pharmacology; 1969; 2(4):217-22. PubMed ID: 5807063 [No Abstract] [Full Text] [Related]
39. Conversion of ergolines to hexahydro- and octahydrobenzo[f]quinolines (depyrroloergolines). Bach NJ; Kornfeld EC; Clemens JA; Smalstig EB J Med Chem; 1980 Jul; 23(7):812-4. PubMed ID: 7190615 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Mawson C; Whittington H Br J Pharmacol; 1970 May; 39(1):223P-224P. PubMed ID: 5420115 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]